ReviewDrugs & aging2016

Targeting Low Disease Activity in Elderly-Onset Rheumatoid Arthritis: Current and Future Roles of Biological Disease-Modifying Antirheumatic Drugs.

Takahiko Sugihara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.